Lyle Arnold,
Chief Scientific Officer
Dr. Arnold currently serves as CSO at Biocept. In 2010 he founded AEGEA Biotechnologies to acquire, develop, and commercialize, next generation nucleic acid technologies. Dr. Arnold also serves on the board of directors of Asuragen, as well as on the board of AEGEA. Previously, Dr. Arnold held various senior scientific and management positions at Molecular Biosystems (co-founder), Gen-Probe, Genta, Synteni, Incyte Genomics, and Oasis Biosciences (co-founder). Additionally, Dr. Arnold was a faculty member in the UCSD School of Medicine and a member of the UCSD Cancer Center. He is an inventor or co-inventor on 44 issued U.S. patents and more than 140 issued and pending patents worldwide. Dr. Arnold has authored more than 50 scientific publications. He received a B.S. in Chemistry from the University of California at Los Angeles and a Ph.D. in Chemistry/Biochemistry from the University of California at San Diego.
|
|
|
